American Journal of Ophthalmology
Volume 148, Issue 1 , Pages 128-135.e2, July 2009

Incidence of Cystoid Macular Edema after Cataract Surgery in Patients with and without Uveitis Using Optical Coherence Tomography

  • Marie-Lyne Bélair

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationInquiries to Marie-Lyne Bélair, Centre Michel Mathieu, Hôpital Maisonneuve-Rosemont, 5415 Boulevard l'Assomption, Montreal, Quebec H1T 2M4, Canada
  • ,
  • Stephen J. Kim

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Jennifer E. Thorne

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
  • ,
  • James P. Dunn

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Sanjay R. Kedhar

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Diane M. Brown

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Douglas A. Jabs

      Affiliations

    • Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

Accepted 18 February 2009. published online 29 April 2009.

Purpose

To determine the incidence of cystoid macular edema (CME) after cataract surgery among eyes with and without uveitis using optical coherence tomography (OCT) and to determine risk factors for postoperative CME among eyes with uveitis.

Design

Prospective, comparative cohort study.

Methods

Single-center, academic practice. Forty-one eyes with uveitis and 52 eyes without uveitis underwent clinical examination and OCT testing within 4 weeks before cataract surgery and at 1-month and 3-month postoperative visits. The main outcome measure was incidence of CME at 1 and 3 months after surgery.

Results

Both uveitic and control eyes gained approximately 3 lines of vision (P = .6). Incidence of CME at 1 month was 12% (5 eyes) for uveitis and 4% (2 eyes) for controls (P = .2). Incidence of CME at 3 months was 8% (3 eyes) for uveitis and 0% for eyes without uveitis (P = .08). Eyes with uveitis treated with perioperative oral corticosteroids had a 7-fold reduction in postoperative CME (relative risk [RR], 0.14; P = .05). In uveitic eyes, active inflammation within 3 months before surgery increased the risk of CME when compared with eyes without inflammation (RR, 6.19; P = .04). CME was significantly associated with poorer vision (P = .01).

Conclusions

Eyes with well-controlled uveitis may obtain similar outcomes to control eyes after cataract surgery (up to 3 months). Use of perioperative oral corticosteroids and control of uveitis for more than 3 months before surgery seemed to decrease the risk of postoperative CME among uveitic eyes in this study.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Bélair is currently at the Centre Michel Mathieu, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada. Dr Kim is currently at the Department of Ophthalmology, Vanderbilt University School of Medicine, Nashville, Tennessee. Dr Kedhar is currently at the New York Eye & Ear Infirmary, New York, New York. Dr Jabs is currently at the Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York.

PII: S0002-9394(09)00151-2

doi:10.1016/j.ajo.2009.02.029

American Journal of Ophthalmology
Volume 148, Issue 1 , Pages 128-135.e2, July 2009